VANCOUVER, BC, February 24, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that further to its news release dated February 7, 2017 it has successfully entered into a definitive option agreement with a Late Stage Applicant (“OptionCo”) under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to acquire 100% of the outstanding shares of OptionCo from its current shareholders (the “Vendors”).
OptionCo had its Pre-license from Health Canada in early January 2017 and expects to receive a license to cultivate under the ACMPR in short order.
Read more “Invictus MD announces definitive option agreement with Late Stage Applicant under the ACMPR”
VANCOUVER, BC, February 15, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 82.5%, has generated $1.423 million in revenue for the 7 months ending January 31, 2017, with a gross margin of $727,000, representing a 51% gross margin compared to the same period in the prior year gross margin of $446,000, representing a 33% margin.
Chris Pearson, Chief Revenue Officer of Future Harvest commented, “as the demand for cannabis for medical purposes under the ACMPR dramatically rises, Future Harvest is capturing that growth opportunity and we’re becoming a part of the cannabis growth story by providing specialty fertilizer and supplies for the hydroponic cultivation sector. Through several university research partnerships, we are also developing and manufacturing leading edge nutrient formulations tailored to the specific requirements of our clients.” Pearson further stated “We took full advantage of the industry’s growing demands and re-invested approximately $300,000 in a fully automated bottling line capable of handling bottle sizes of 125ml up to 4 liters, at a rate of 40 liters per minute. This addition increases our overall production efficiency by 400% and allows us to aggressively pursue the emerging market opportunities.”
Read more “Invictus MD’s Future Harvest Achieves 63% Increase In Gross Margin For The Past 7 Months”
VANCOUVER, BC, February 10, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce today that it has entered into an agreement with Canaccord Genuity Corp. and Eventus Capital Corp. as co-lead underwriters (collectively, the “Underwriters”) pursuant to which the Underwriters have agreed to purchase, on a bought deal private placement basis 9,100,000 units of the Company (the “Units”), at a price of $1.65 per Unit (the “Offering Price”) for aggregate gross proceeds to the Company of $15,015,000 (the “Offering”).
The Company has agreed to grant the Underwriters an over-allotment option to purchase up to an additional 1,365,000 Units at the Offering Price, exercisable in whole or in part at any time for a period of 48 hours prior to the closing of the Offering. In the event the over-allotment option is exercised in full, the aggregate gross proceeds of the Offering will be C$17,267,250.
Read more “Invictus MD Announces $15,015,000 Bought Deal Private Placement of Units”
VANCOUVER, BC, February 9, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that AB Ventures Inc. (“AB Ventures”), a newly incorporated company formed to develop a second licensed expansion facility through it’s common ownership with AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), has acquired 100 acres in Hamilton, Ontario, for cannabis cultivation and sale under the ACMPR.
The land acquisition, worth $1,650,000 CDN, is scheduled to close on May 1, 2017 and will be used for future cannabis cultivation once licensed under the ACMPR. Plans to construct five production facilities on the new land totaling 100,000 square feet will be completed by 2019. AB Labs is licensed for cultivation under the ACMPR and maintains a 16,000 square foot facility located in Hamilton, Ontario.
Read more “Invictus MD announce that AB Ventures Inc. has acquired 100 acres for future cannabis cultivation and sale under the ACMPR”